- Home
- AUTL vs NPCT Comparison
AUTL vs NPCT Comparison
Compare AUTL & NPCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- NPCT
- Stock Information
- Founded
- AUTL 2014
- NPCT 2020
- Country
- AUTL United Kingdom
- NPCT United States
- Employees
- AUTL N/A
- NPCT N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- NPCT Investment Managers
- Sector
- AUTL Health Care
- NPCT Finance
- Exchange
- AUTL Nasdaq
- NPCT Nasdaq
- Market Cap
- AUTL 360.6M
- NPCT 307.4M
- IPO Year
- AUTL 2018
- NPCT N/A
- Fundamental
- Price
- AUTL $1.51
- NPCT $10.01
- Analyst Decision
- AUTL Strong Buy
- NPCT
- Analyst Count
- AUTL 5
- NPCT 0
- Target Price
- AUTL $9.32
- NPCT N/A
- AVG Volume (30 Days)
- AUTL 2.0M
- NPCT 107.1K
- Earning Date
- AUTL 05-08-2025
- NPCT 01-01-0001
- Dividend Yield
- AUTL N/A
- NPCT 9.82%
- EPS Growth
- AUTL N/A
- NPCT N/A
- EPS
- AUTL N/A
- NPCT N/A
- Revenue
- AUTL $10,120,000.00
- NPCT N/A
- Revenue This Year
- AUTL $277.74
- NPCT N/A
- Revenue Next Year
- AUTL $221.89
- NPCT N/A
- P/E Ratio
- AUTL N/A
- NPCT N/A
- Revenue Growth
- AUTL 496.00
- NPCT N/A
- 52 Week Low
- AUTL $1.11
- NPCT $8.58
- 52 Week High
- AUTL $5.00
- NPCT $10.63
- Technical
- Relative Strength Index (RSI)
- AUTL 49.38
- NPCT 38.23
- Support Level
- AUTL $1.32
- NPCT $9.83
- Resistance Level
- AUTL $1.45
- NPCT $10.07
- Average True Range (ATR)
- AUTL 0.16
- NPCT 0.26
- MACD
- AUTL 0.04
- NPCT -0.01
- Stochastic Oscillator
- AUTL 65.85
- NPCT 25.26
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About NPCT Nuveen Core Plus Impact Fund of Beneficial Interest
Nuveen Core Plus Impact Fund is an organized, diversified, closed-end management investment company. The Fund's investment objective is to seek total return through high current income and capital appreciation, while giving special consideration to certain impact and environmental, social and governance criteria.